Market research
ALPA.NSE Alpa Laboratories Limited
NSE INR Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 1B
- P/E ratio
- 29.11
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.9
Community
Investor discussion
1 comment
Sign in to join the ALPA.NSE discussion.
5 years, 6 months ago
Alpa Laboratories Limited is currently in a long term uptrend where the price is trading 14.4% above its 200 day moving average.
From a valuation standpoint, the stock is 85.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.7.
Alpa Laboratories Limited's total revenue rose by 37.5% to $332M since the same quarter in the previous year.
Its net income has increased by 44.6% to $37M since the same quarter in the previous year.
Based on the above factors, Alpa Laboratories Limited gets an overall score of 4/5.